# Akso Health Group: financial statements, quarterly

AHG · Nasdaq · CIK 1702318 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/ahg.md) · [Financials](/companies/ahg/financials.md) · [Filings](/companies/ahg/filings.md) · [Insiders](/companies/ahg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ahg/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-03-31) | period not labelled (2017-03-31) | FY2018 (2018-03-31) | FY2019 (2019-03-31) | FY2020 (2020-03-31) | FY2021 (2021-03-31) | period not labelled (2021-04-30) | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.8](/filings/0001104659-18-047800.md) | [19.2](/filings/0001104659-18-047800.md) | [133](/filings/0001104659-19-042798.md) | [57.4](/filings/0001104659-20-095568.md) | [6.7](/filings/0001104659-21-096667.md) | [15.1](/filings/0001104659-22-130935.md) | not reported | [18.4](/filings/0001213900-23-057106.md) | [7.9](/filings/0001213900-25-076862.md) | [85.2](/filings/0001213900-26-080868.md) | [176](/filings/0001213900-26-080868.md) | [0.2](/filings/0001213900-26-080868.md) |
| Current assets | $m | not reported | not reported | [163](/filings/0001104659-19-042798.md) | [97.7](/filings/0001104659-20-095568.md) | [52.0](/filings/0001104659-21-096667.md) | [30.1](/filings/0001104659-22-130935.md) | not reported | [62.8](/filings/0001213900-23-057106.md) | [20.5](/filings/0001013762-24-002658.md) | [142](/filings/0001213900-25-076862.md) | [196](/filings/0001213900-26-080868.md) | [190](/filings/0001213900-26-080868.md) |
| Total assets | $m | not reported | [28.4](/filings/0001104659-18-047800.md) | [164](/filings/0001104659-19-042798.md) | [173](/filings/0001104659-20-095568.md) | [80.5](/filings/0001104659-21-096667.md) | [31.7](/filings/0001104659-22-130935.md) | not reported | [62.8](/filings/0001213900-23-057106.md) | [20.5](/filings/0001013762-24-002658.md) | [142](/filings/0001213900-25-076862.md) | [215](/filings/0001213900-26-080868.md) | [190](/filings/0001213900-26-080868.md) |
| Current liabilities | $m | not reported | not reported | [23.8](/filings/0001104659-19-042798.md) | [26.6](/filings/0001104659-20-095568.md) | [12.4](/filings/0001104659-21-096667.md) | [14.4](/filings/0001104659-22-130935.md) | not reported | [50.5](/filings/0001213900-23-057106.md) | [11.6](/filings/0001013762-24-002658.md) | [3.6](/filings/0001213900-25-076862.md) | [13.8](/filings/0001213900-26-080868.md) | [8.7](/filings/0001213900-26-080868.md) |
| Total liabilities | $m | not reported | [4.9](/filings/0001104659-18-047800.md) | [23.8](/filings/0001104659-19-042798.md) | [46.8](/filings/0001104659-20-095568.md) | [32.4](/filings/0001104659-21-096667.md) | [14.4](/filings/0001104659-22-130935.md) | not reported | [50.5](/filings/0001213900-23-057106.md) | [11.6](/filings/0001013762-24-002658.md) | [3.6](/filings/0001213900-25-076862.md) | [15.8](/filings/0001213900-26-080868.md) | [8.7](/filings/0001213900-26-080868.md) |
| Shareholders' equity | $m | [14.0](/filings/0001104659-19-042798.md) | [23.5](/filings/0001104659-18-047800.md) | [140](/filings/0001104659-19-042798.md) | [127](/filings/0001104659-20-095568.md) | [48.1](/filings/0001104659-21-096667.md) | [17.3](/filings/0001104659-22-130935.md) | [17.3](/filings/0001013762-24-002658.md) | [12.3](/filings/0001213900-23-057106.md) | [8.7](/filings/0001013762-24-002658.md) | [138](/filings/0001213900-25-076862.md) | [199](/filings/0001213900-26-080868.md) | [181](/filings/0001213900-26-080868.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

Shares outstanding: 1,655,583,530 at 2025-03-31, from the cover of the [20-F filed 2025-08-14](/filings/0001213900-25-076862.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.